Furthermore our data propose a novel molecular mechanism whereby PGE2 biosynthesis, driven by elevated expression of PTGS2 in endometrial adenocarcinoma cells, and hypoxia synergise to increase PTGER4 expression and subsequently enhance cell proliferation and tumour growth. The gene discussed is PTGER4; the disease is neoplasm.